BIOVIA Generative Therapeutics Design: Accelerate Drug Design with AI and 3D MODSIM

A large, research-based bio-pharmaceutical company partnered with BIOVIA in a pilot program to re-identify lead drug candidates.

Read this use case to learn how the customer leveraged BIOVIA’s AI-driven ideation tool, Generative Therapeutics Design (GTD) on 3DEXPERIENCE® Platform to:

• Incorporate 3D information for protein-ligand interactions to improve AI and ML models for small molecule drug design.
• Re-identify lead compounds in clinical development within months, along with 41 closely related compounds.
• Generate additional, novel chemical compounds that are slated for future testing.